Table of Contents Table of Contents
Previous Page  133 / 264 Next Page
Information
Show Menu
Previous Page 133 / 264 Next Page
Page Background

5. Tomlin J, Chang D, McCutcheon B, Harris J. Surgical technique and

recurrence in cholesteatoma: a meta-analysis.

Audiol Neurootol

2013;18:

135–142.

6. Brown JS. A ten year statistical follow-up of 1142 consecutive cases of cho-

lesteatoma: the closed vs. the open technique.

Laryngoscope

1982;92:

390–396.

7. Nyrop M, Bonding P. Extensive cholesteatoma: Long-term results of three

surgical techniques.

J Laryngol Otol

1997;111:521–526.

8. Kos MI, Castrillon R, Montandon P, Guyot JP. Anatomic and functional

long-term results of canal wall-down mastoidectomy.

Ann Otol Rhinol

Laryngol

2004;113:872–876.

9. Jackler RK. The surgical anatomy of cholesteatoma.

Otolaryngol Clin

North Am

1989;22:883–896.

10. Neudert M, Lailach S, Lasurashvili N, Kemper M, Beleites T, Zahnert T.

Cholesteatoma recidivism: comparison of three different surgical techni-

ques.

Otol Neurotol

2014;35:1801–1808.

11. Kuo CL, Liao WH, Shiao AS. A review of current progress in acquired cho-

lesteatoma management.

Eur Arch Otorhinolaryngol.

2014. Epub ahead

of print.

12. Abramson M, Lachenbruch PA, Press BH, McCabe BF. Results of conservative

surgery for middle ear cholesteatoma.

Laryngoscope

1977;87:1281–1287.

13. Yang WY, Watson C. Post-operative follow up of cholesteatoma-how long is

adequate?

Clin Otolaryngol

2012;37:160.

14. Lau T, Tos M. Tensa retraction cholesteatoma: treatment and long-term

results.

J Laryngol Otol

1989;103:149–157.

15. Stankovic M. Follow-up of cholesteatoma surgery: open versus closed tym-

panoplasty.

ORL J Otorhinolaryngol Relat Spec

2007;69:299–305.

16.

Cochrane Handbook

. 9.5.2 identifying and measuring heterogeneity.

http:// handbook.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_het- erogeneity.htm

. Accessed January 13, 2015.

17. Charachon R, Roux O, Eyraud S. Cholesteatoma of the middle ear. Choice

of technique and results in the adult and child.

Ann Otolaryngol Chir

Cervicofac

1980;97:65–78.

18. Roden D, Honrubia VF, Wiet R. Outcome of residual cholesteatoma and

hearing in mastoid surgery.

J Otolaryngol

1996;25:178–181.

19. Ajalloueyan M. Surgery in cholesteatoma: ten years follow-up.

Iran J Med

Sci

2006;31:37–40.

20. Palmgren O. Long-term results of open cavity and tympanomastoid sur-

gery of the chronic ear.

Acta Otolaryngol

1979;88:343–349.

21. House WF, Sheehy JL. Functional restoration in tympanoplasty.

Arch Oto-

laryngol

1963;78:304–309.

22. Quaranta A, Cassano P, Carbonara G. Cholesteatoma surgery: Open vs

closed tympanoplasty.

Am J Otol

1988;9:229–231.

23. Ikeda M, Yoshida S, Ikui A, Shigihara S. Canal wall down tympanoplasty

with canal reconstruction for middle-ear cholesteatoma: post-

operative hearing, cholesteatoma recurrence, and status of re-

aeration of reconstructed middle-ear cavity.

J Laryngol Otol

2003;117:

249–255.

24. Gerlach H. Is the “second look” justified after cholesteatoma surgery

according to the closed technique? (our concept of “indicator-pearl”).

Lar-

yngol Rhinol Otol (Stuttg)

1982;61:294–296.

25. Elefante A, Cavaliere M, Russo C, et al. Diffusion weighted MR imaging

of primary and recurrent middle ear cholesteatoma: an assessment

by readers with different expertise.

Biomed Res Int

2015;2015:597896.

26. Quaranta N, Iannuzzi L, Petrone P, D’Elia A, Quaranta A. Quality of life

after cholesteatoma surgery: intact-canal wall tympanoplasty versus

canal wall-down tympanoplasty with mastoid obliteration.

Ann Otol Rhi-

nol Laryngol

2014;123:89–93.

27. Vartiainen E. Factors associated with recurrence of cholesteatoma.

J Laryngol Otol

1995;109:590–592.

28. Lynrah ZA, Bakshi J, Panda NK, Khandelwal NK. Aggressiveness of pedi-

atric cholesteatoma. Do we have an evidence?

Indian J Otolaryngol

Head Neck Surg

2013;65:264–268.

29. Stapleton AL, Egloff AM, Yellon RF. Congenital cholesteatoma: predictors

for residual disease and hearing outcomes.

Arch Otolaryngol Head Neck

Surg

2012;138:280–285.

30. Visvanathan V, Kubba H, Morrissey MS. Cholesteatoma surgery in chil-

dren: 10-year retrospective review.

J Laryngol Otol

2012;126:450–453.

31. Ahn SH, Oh SH, Chang SO, Kim CS. Prognostic factors of recidivism in

pediatric cholesteatoma surgery.

Int J Pediatr Otorhinolaryngol

2003;67:

1325–1330.

32. Lazard DS, Roger G, Denoyelle F, Chauvin P, Garabedian EN. Congenital

cholesteatoma: risk factors for residual disease and retraction pockets—

a report on 117 cases.

Laryngoscope

2007;117:634–637.

33. Stangerup SE, Drozdziewicz D, Tos M. Cholesteatoma in children, predic-

tors and calculation of recurrence rates.

Int J Pediatr Otorhinolaryngol

1999;49(suppl 1):S69–S73.

34. Roger G, Denoyelle F, Chauvin P, Schlegel-Stuhl N, Garabedian EN. Pre-

dictive risk factors of residual cholesteatoma in children: a study of 256

cases.

Am J Otol

1997;18:550–558.

35. Iino Y, Imamura Y, Kojima C, Takegoshi S, Suzuki JI. Risk factors for

recurrent and residual cholesteatoma in children determined by second

stage operation.

Int J Pediatr Otorhinolaryngol

1998;46:57–65.

36. Roux A, Bakhos D, Lescanne E, Cottier JP, Robier A. Canal wall recon-

struction in cholesteatoma surgeries: rate of residual.

Eur Arch Otorhi-

nolaryngol

2014. Epub ahead of print.

37. Muir Gray, JA. Evidence-Based Healthcare and Public Health: How to

Make Decisions About Health Services and Public Health. Edinburgh,

Scotland; New York, NY: Churchill Livingstone/Elsevier; 2009.

Laryngoscope 126: April 2016

Kerckhoffs et al.: A Review on Cholesteatoma Recidivism After CWU and CWD

112